Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?
Molecular Diagnosis & Therapy · 2024
DOI: 10.1007/s40291-024-00726-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, 2024. Verfasst von Yi Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Univers…. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Recombinational DNA Repair, Mutation, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: There is no consensus regarding the specific genes included in the homologous recombination repair (HRR) gene panel for identifying the HRR deficiency (HRD) status and predicting the prognosis of epithelial ovarian cancer (EOC) patients. OBJECTIVE: We aimed to explore a 15-gene panel involving the HRR pathway as a predictive prognostic indicator in Chinese patients newly diagnosed with EOC. PATIENTS AND METHODS: We reviewed the previously published reports about different HRR gene panels and prespecified the 15-gene panel. The genetic testing results in a 15-gene panel from 308 EOC patients diagnosed between 2014 and 2022 from six centers were collected. The association of clinicopathologic characteristics, the use of poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPis) and progression-free survival (PFS) with 15-gene panel HRR mutations (HRRm) status was assessed. RESULTS: 43.2% (133/308) of patients were determined to carry 144 deleterious HRRm, among which 68.1% (98/144) were germline mutations and 32.8% (101/308) were BRCA1/2 gene lethal mutations. The hazard ratio (HR) (95% confidence interval, CI) for PFS (HRRm v HRR wild type, HRRwt) using the 15-gene panel HRRm was 0.42 (0.28-0.64) at all stages and 0.42 (0.27-0.65) at stages IIIC-IV. However, a prognostic difference was observed only between the BRCA mutation group and the HRRwt group, not between the non-BRCA HRRm group and the HRRwt group. For the subgroups of patients not using PARPis, the HR (95% CI) was 0.41 (0.24-0.68) at stages IIIC-IV. CONCLUSIONS: This study provides evidence that 15-gene panel HRRm can predict the prognosis of EOC, of these only the BRCA1/2 mutations, not non-BRCA HRRm, contribute to prognosis prediction. Among patients without PARPis, the HRRm group presented a better PFS. This is the first study of this kind in the Chinese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
- Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-an Road, Shanghai, 200032, China.
- Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510000, China.
- Department of Gynecological Oncology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200082, China.
- Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC, Hefei, 230001, China.
- Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China.
ORCID-Profile: Ying Zhou
Zitieren
APA
Liu, Y., Chen, X., Lu, H., Wu, X., Liu, X., Xu, F., Ye, D., Ding, B., Lu, X., Qiu, L., Zhu, J., Wang, Y., Huang, X., Shen, Z., Zhu, T., Shen, Y., & Zhou, Y. (2024). Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00726-w
Vancouver
Liu Y, Chen X, Lu H, Wu X, Liu X, Xu F, et al. Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?. Molecular Diagnosis & Therapy. 2024. doi:10.1007/s40291-024-00726-w
BibTeX
@article{Liu2024,
author = {Liu, Yi and Chen, Xiaojun and Lu, Huaiwu and Wu, Xin and Liu, Xuehan and Xu, Fei and Ye, Dongdong and Ding, Bo and Lu, Xiaoyan and Qiu, Ling and Zhu, Jing and Wang, Yingying and Huang, Xinya and Shen, Zhen and Zhu, Tao and Shen, Yang and Zhou, Ying},
title = {Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?},
journal = {Molecular Diagnosis & Therapy},
year = {2024},
doi = {10.1007/s40291-024-00726-w}
}
EUVIMED